A detailed history of Barclays PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Barclays PLC holds 2,669 shares of QURE stock, worth $42,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,669
Previous 2,669 -0.0%
Holding current value
$42,010
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$3.78 - $10.12 $5,877 - $15,736
1,555 Added 139.59%
2,669 $13,000
Q2 2024

Aug 14, 2024

SELL
$4.39 - $5.43 $1,374 - $1,699
-313 Reduced 21.93%
1,114 $5,000
Q1 2024

May 15, 2024

SELL
$4.82 - $6.93 $713,562 - $1.03 Million
-148,042 Reduced 99.05%
1,427 $7,000
Q4 2023

Feb 15, 2024

SELL
$5.63 - $8.27 $4.73 Million - $6.95 Million
-840,093 Reduced 84.9%
149,469 $1.01 Million
Q3 2023

Nov 07, 2023

BUY
$6.71 - $11.83 $5.58 Million - $9.84 Million
831,929 Added 527.76%
989,562 $6.64 Million
Q2 2023

Aug 03, 2023

BUY
$11.12 - $22.2 $1 Million - $2 Million
90,148 Added 133.58%
157,633 $1.81 Million
Q1 2023

May 04, 2023

SELL
$18.7 - $23.07 $739,772 - $912,649
-39,560 Reduced 36.96%
67,485 $1.36 Million
Q4 2022

Feb 13, 2023

SELL
$18.12 - $27.32 $575,219 - $867,273
-31,745 Reduced 22.87%
107,045 $2.43 Million
Q3 2022

Nov 03, 2022

BUY
$16.98 - $25.54 $2.2 Million - $3.3 Million
129,286 Added 1360.33%
138,790 $2.6 Million
Q2 2022

Aug 12, 2022

SELL
$13.15 - $20.45 $182,982 - $284,561
-13,915 Reduced 59.42%
9,504 $177,000
Q1 2022

May 16, 2022

BUY
$14.54 - $21.5 $292,297 - $432,214
20,103 Added 606.24%
23,419 $424,000
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $369,258 - $656,966
-18,244 Reduced 84.62%
3,316 $69,000
Q3 2021

Nov 09, 2021

BUY
$26.01 - $38.22 $532,736 - $782,822
20,482 Added 1900.0%
21,560 $690,000
Q2 2021

Aug 13, 2021

SELL
$29.97 - $37.17 $275,124 - $341,220
-9,180 Reduced 89.49%
1,078 $33,000
Q1 2021

May 13, 2021

SELL
$29.24 - $42.03 $17,690 - $25,428
-605 Reduced 5.57%
10,258 $346,000
Q4 2020

Feb 11, 2021

BUY
$35.35 - $50.67 $16,826 - $24,118
476 Added 4.58%
10,863 $392,000
Q3 2020

Nov 12, 2020

SELL
$35.98 - $47.66 $89,914 - $119,102
-2,499 Reduced 19.39%
10,387 $382,000
Q2 2020

Aug 12, 2020

BUY
$45.06 - $67.74 $580,643 - $872,897
12,886 New
12,886 $581,000
Q1 2020

May 13, 2020

SELL
$40.01 - $73.97 $840 - $1,553
-21 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$37.13 - $74.62 $296,297 - $595,467
-7,980 Reduced 99.74%
21 $2,000
Q3 2019

Nov 14, 2019

BUY
$39.36 - $76.8 $39 - $76
1 Added 0.01%
8,001 $315,000
Q2 2019

Aug 14, 2019

SELL
$52.76 - $82.19 $107,630 - $167,667
-2,040 Reduced 20.32%
8,000 $625,000
Q1 2019

May 15, 2019

BUY
$27.39 - $68.41 $214,135 - $534,829
7,818 Added 351.85%
10,040 $598,000
Q4 2018

Feb 14, 2019

BUY
$22.8 - $33.93 $1,162 - $1,730
51 Added 2.35%
2,222 $64,000
Q3 2018

Nov 14, 2018

SELL
$29.75 - $43.08 $522,439 - $756,527
-17,561 Reduced 89.0%
2,171 $80,000
Q2 2018

Aug 14, 2018

SELL
$21.96 - $39.94 $604,053 - $1.1 Million
-27,507 Reduced 58.23%
19,732 $745,000
Q1 2018

May 15, 2018

SELL
$17.1 - $26.61 $388,101 - $603,940
-22,696 Reduced 32.45%
47,239 $1.11 Million
Q4 2017

Feb 14, 2018

BUY
$9.47 - $19.59 $477,761 - $988,315
50,450 Added 258.92%
69,935 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$7.7 - $9.6 $150,034 - $187,056
19,485
19,485 $187,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $736M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.